An imported case of Bundibugyo virus disease in Kenya raises questions about airport screening, clinical recognition, and potential exposures, highlighting the importance of coordinated contact tracing and hospital infection prevention readiness.
|Articles|September 7, 2014
Updated SHEA Guidelines Include Agion Antimicrobial-Treated Catheters
Advertisement
Use of catheters containing the Agion® antimicrobial is among the recommended strategies to control central line-associated bloodstream infections (CLABSI) according to the Society for Healthcare Epidemiology of America (SHEA).
An expert guidance document published in Infection Control and Hospital Epidemiology in the July 2014 issue provides best evidence practices for the prevention of central-line associated bloodstream infections. As part of the 2014 updates, the authors recommend the use of “silver zeolite–impregnated umbilical catheters in preterm infants,” based on the 2012 study by Bertini on the “Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the Agion Antimicrobial System.”
“SHEA’s recommendations should encourage more hospitals to expand the use of antimicrobial device technologies available to prevent central-line associated bloodstream infections, when the basic CLABSI prevention strategies fail to lower infection rates to acceptable levels,” says Paul C. Ford, chief executive officer of Sciessent. “Studies that prove the safety and efficacy of these antimicrobial protected devices provide the foundation for the SHEA expert guidance, and implementation will lead to better care and outcomes in terms of CLABSI prevention.”
The SHEA guidelines also recommend the use of “antimicrobial-impregnated central venous catheters (CVCs) in adult patients” to prevent CLABSI. Both recommendations highlighted by SHEA are among the special approaches currently available for use “in locations and/or populations within the hospital with unacceptably high CLABSI rates.”
The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration; those medical device claims are based on safety and efficacy testing and are limited to those approved by FDA.
Source: Sciessent
Advertisement
Related to this article
Florida’s dengue outbreak highlights the importance of recognizing symptoms, identifying warning signs, and preventing mosquito bites. Ubong Johnson, MD, explains local transmission, diagnostic testing, treatment, and practical prevention measures.
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.
Advertisement
Advertisement